z-logo
open-access-imgOpen Access
SALVADORA PERSICA;
Author(s) -
Talea Hoor,
Riffat Farooqu,
Jan Mohammad Shaikh,
Nasim Karim
Publication year - 2018
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2014.21.01.1900
Subject(s) - medicine , saline , aspirin , carrageenan , edema , body weight , distilled water , pharmacology , anesthesia , chromatography , chemistry
Objective: To evaluate anti-inflammatory activity of Salvadora persicain rats.Materials & methods: The anti-inflammatory activity of Salvadora persica was assessed in 63albino rats of both sexes, weighing 400 gm. They were divided into three groups, A (control), B(crude drug), C (standard drug) with twenty one animals. Each group was divided into threesubgroups with seven animals. Groups B &C were given crude drug and aspirin diluted in one mlof distilled water once daily orally, in doses of 300, 500, & 700 mg/kg body weight respectively,prior to induction of edema and Group A was given same volume of saline. Inflammation wasinduced in hind paw of rat by sub-planter injection of 0.1ml of 1% carrageenan. Paw volume wasmeasured in terms of milliliters using plethysmometer, immediately before injection & then hourlyup to 5 hours& mean was calculated. The inhibition of edema was calculated for each subgroupwith respect to control group. Results: After carrageenan injection mean paw volume of controlgroup was 5.43 ml, while that of drug treated subgroup was 4.32 ml & standard group was 4.49 mlat the dose of 700 mg/kg body weight. Comparison of crude drug with the control was found to bestatistically significant only at 700 mg/kg & was comparable with the standard drug aspirin.Conclusions: Salvadora persica has shown anti-inflammatory activity by decreasing the pawvolume of carageenan induced edema.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here